Semiautomated platform delivers consistent batches of extracellular vesicles for potential regenerative therapies

The Quick Take
A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Blood and Tissue Bank (BST) has developed and validated a manufacturing platform for extracellular vesicles that meets pharmaceutical quality requirements, marking a key step toward their clinical application.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Phys.org - latest science and technology news stories.
Related
Science
Shared data ecosystem could help scientists explore new biological connections
Scientists generate vast amounts of research data, but connecting information across studies can be difficult. The NIH Common Fund Data Ecosystem is working to…
Science
Digitalization front-runners are more vulnerable to cyberattacks
For many business leaders, digitalization is associated with promises of greater efficiency and productivity. However, a new study by professor of accounting…
Science
Percentage of votes counted so far
For the Washington Post, Dylan Moriarty has a live tracker for the percentage… Tags: turnout , voting , Washington Post
Local
Needle of uncertainty is live for Midterms 2026
If feeling uncertain is your thing, the Needle from the New York Times… Tags: election , midterm , needle , New York Times , uncertainty
